Related Experiment Video
Updated: May 16, 2026
13:04
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
Published on: March 18, 2015
Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges
Vivek A Kumar1, Luke P Brewster, Jeffrey M Caves
1Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, GA 30332.
Cardiovascular Engineering and Technology
|November 28, 2012
Summary
Tissue-engineered blood vessels offer a promising solution for small-diameter replacements due to limitations of current grafts. Research focuses on biomaterials, cell biology, and regenerative medicine for improved vascular replacements.
Area of Science:
- Biomaterials Science
- Cell Biology
- Regenerative Medicine
- Translational Medicine
Background:
- Vascular disease limits autologous tissue availability for small-diameter (< 6 mm) vessel replacement.
- Synthetic vascular grafts have not met the performance standards of natural conduits.
- Tissue-engineered vascular grafts (TEVGs) are an ideal solution for vascular replacement.
Purpose of the Study:
- To review current limitations of autologous and synthetic vascular grafts.
- To outline engineering requirements for TEVG implantation.
- To present the current status of tissue-engineered blood vessel research.
Main Methods:
- Review of scientific literature on vascular graft technologies.
- Analysis of clinical outcomes and challenges in TEVG development.
- Synthesis of interdisciplinary approaches in biomaterials science, cell biology, and translational medicine.
Main Results:
- Significant global interest and progress in blood vessel tissue engineering over two decades.
- First clinical implants of multiple TEVG technologies have been achieved.
- Critical lessons learned regarding mechanical support, hemocompatibility, and tissue regeneration.
Conclusions:
- TEVGs represent a viable and ideal solution for small-diameter vascular replacements.
- Continued interdisciplinary research is crucial for developing feasible and effective TEVGs.
- Addressing engineering requirements will advance the clinical application of TEVGs.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:07Development of Blood Vessels
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...